Excision Logo home

SAFE

Targets non-human viral genomes minimizing chance of off-target cuts

CURATIVE

Removes non-human DNA to return the genome to normal or near-normal

EFFICIENT

Excision products require one-time gene edit to remove the viral genome permanently

“I am optimistic that Excision’s technology and approach using CRISPR could potentially cure infectious diseases and bring much needed therapies to those in need around the world.”

FierceBiotech

JUN 2020

Biopharma tackles COVID-19, HIV and other viruses with gene and cell therapies

Excision Bio Announces Data Presentation at CROI from IND-Enabling Non-Human Primate Studies of EBT-001, Supporting a CRISPR Gene Editing Technology for HIV Elimination

PRESS RELEASE

MAR 2020

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice

NATURE COMMUNICATIONS

JUL 2019

988 Market Street
San Francisco, CA 94102
USA

1755 N. 13th Street #274
Philadelphia, PA 19122
USA

© 2020 Excision BioTherapeutics. All Rights Reserved.